CirrusDx, Inc. (CirrusDx), an infectious disease laboratory and diagnostics company, today announced it now offers ...
The company's rapid antimicrobial susceptibility testing platform can deliver results in under three hours, helping hospitals ...
Karnataka launches a statewide antimicrobial resistance surveillance program with TIGS to track resistance trends and inform ...
Cosmos Health Inc. ('Cosmos Health” or the 'Company”)(NASDAQ:COSM), a diversified, vertically integrated global healthcare ...
A Southampton firm developing rapid antimicrobial susceptibility testing technology to identify the right antibiotics for bacterial infections has closed an oversubscribed £5m funding round.
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...
In the fight against antimicrobial resistance, the greatest danger is often what cannot be seen right away. A patient arrives ...
MOROGORO: THE Ministries of Health in Tanzania and Zanzibar, in partnership with the Ministry of Livestock and Fisheries, and ...
A 45-reference UltraGene range, new respiratory panels and high-multiplex prototypes strengthen ABL Diagnostics ...
Seegene, a global molecular diagnostics company, announced the European launch of its new antimicrobial resistance (AMR) ...
Broadens testing scope from antimicrobial-resistant enteric bacteria to high-risk multidrug-resistant organisms (MDROs) in hospital settingsSupports rapid first-line PCR screening to help enable ...
COSM READ THE FULL COSM RESEARCH REPORT Cosmos Health (NASDAQ: COSM) continues to execute on its strategy of building a diversified healthcare platform with the announcement that it is entering the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results